The present invention relates to the delivery of anti-migraine compounds through an inhalation route. Specifically, it relates to aerosols containing sumatriptan, frovatriptan, or naratriptan that are used in inhalation therapy. In a method aspect of the present invention, sumatriptan, frovatriptan, or naratriptan is administered to a patient through an inhalation route. The method comprises: a) heating a thin layer of sumatriptan, frovatriptan, or naratriptan on a solid support to form a vapor; and, b) passing air through the heated vapor to produce aerosol particles having less than 5% drug degradation products. In a kit aspect of the present invention, a kit for delivering sumatriptan, frovatriptan, or naratriptan through an inhalation route is provided which comprises: a) a thin coating of a sumatriptan, frovatriptan, or naratriptan composition; and, b) a device for dispending said thin coating as a condensation aerosol.

 
Web www.patentalert.com

< Method of forming composite arrays of single-wall carbon nanotubes and compositions thereof

< Systems for differential ion mobility analysis

> Photochromic, photochromic material and method for manufacturing the same

> Nonaqueous secondary battery, method for making negative electrode component therefor, and apparatuses for evaluating and making graphite material for negative electrode component

~ 00241